AzTrials
AzTrials

AnaesthesiaPhase 1/2NCT01677442

Nonintubated Thoracic Epidural Anesthesia Versus Double-lumen Intubated Anesthesia in Video-assisted Thoracic Surgery

A Phase 1/2 study testing no-intubated thoracic epidural anesthesia and double-lumen endotracheal intubated anesthesia in people with Anaesthesia and Video Assisted Thoracic Surgery, run by Guangzhou Institute of Respiratory Disease at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to compare results of general Video-assisted Thoracic Surgery (VATS) operations under no-intubated thoracic epidural anesthesia (NTEA) versus those of a control group operated under general anesthesia with double-lumen endotracheal intubation. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Anaesthesia, Video Assisted Thoracic Surgery
What is being tested?
no-intubated thoracic epidural anesthesia and double-lumen endotracheal intubated anesthesia
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
500 participants
Where
1 siteChina
Study dates
Jul 2011to Jul 2015
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age between 18 and 65 years old
  • signed inform consent
  • Tumor size < 6 cm without right or left bronchus invasion
  • Predicted FEV 1.0 > 60% or FEV1.0 > 1.5L
  • EF > 50%
  • PCO2 < 50mmHg,PO2 > 60mmHg(without uptaking oxygen)

Who cannot join

  • Psychopath patients who cannot cooperate
  • ASA score greater than 3
  • A history of tuberculosis or other signs of intrapleural adhesions
  • spinal malformation
  • Hypovolemia or coagulation disorders
  • BMI > 30
  • Unfavorable reasons judged by anesthesiologist or surgeon

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • the First Affiliated Hospital of Guangzhou Medical College

    Guangzhou, Guangdong, 510000

    Fei Cui, MD.,PhD, 08618902301212, 4641121@qq.com

    Recruiting

Other trials in China

About this study

The purpose of this study is to compare results of general Video-assisted Thoracic Surgery (VATS) operations under no-intubated thoracic epidural anesthesia (NTEA) versus those of a control group operated under general anesthesia with double-lumen endotracheal intubation.

Read the detailed description

The thoracoscopic surgery always requires not only an appropriate depth of anaesthesia, but also a quiet and wide operative field. That's why anaesthesia plays a critical role in thoracoscopic surgery.

General double-lumen endotracheal intubated anesthesia with one-lung ventilation, has been accepted mandatory for Video-Assisted Thoracic Surgery (VATS) although several adverse effects can derive from this type of anesthesia like intubation-related throat injury, ventilator-induced lung injury, arrhythmia and so on. The investigators hypothesize that VATS could be performed under the no-intubated thoracic epidural anesthesia (NTEA) to avoid general anesthesia related risks.

Some cases have been reported to prove the safety and feasibility of NTEA in uncomplicated VATS. However, the comparison of NTEA and general anesthesia has been rarely investigated in such a larger magnitude number and such operation varieties. The investigators hypothesize NTEA could result in less inflammations, lower incidence of complications, less dosage of antibiotic, faster recovery eventually leading to a shorter hospital stay. For this reason, the investigators will undertaken a randomized trial comparing results of general VATS operations under NTEA versus those of a control group operated under general anesthesia with double-lumen endotracheal intubation.

A total of 500 patients will be included. The study will be performed in the first affiliated hospital of Guangzhou Medical College.

Being tested
no-intubated thoracic epidural anesthesia, double-lumen endotracheal intubated anesthesia
Keywords
nonintubated, anaesthesia, VATS

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • no-intubated thoracic epidural anesthesiaProcedure or surgery

    VATS under no-intubated thoracic epidural anesthesia

  • double-lumen endotracheal intubated anesthesiaProcedure or surgery

    VATS under double-lumen endotracheal intubated anesthesia

Study groups in NCT01677442
Study groupRoleWhat they receive
no-intubated groupExperimentalExperimental: no-intubated thoracic epidural anesthesia Thoracic epidural anesthesia at the T5/T6 thoracic interspace
Receives: Procedure: no-intubated thoracic epidural anesthesia
intubated groupActive comparatorActive Comparator:double-lumen endotracheal intubated anesthesia
Receives: Procedure: double-lumen endotracheal intubated anesthesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. recovery time after intervention of each group

    the time of anesthesia recovery, resumption of oral intake, and the length of hospital stay

    Measured: 7 days

Secondary outcomes (1)
  1. incidence of complications

    Measured: 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Sep 2012 (estimated)
  2. Study startJul 2011
  3. Primary completionJul 2014 (estimated)
  4. Study completionJul 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01677442
Sponsor's protocol ID
NTEA001
Status last verified
Apr 2012
First submitted
4 May 2012
Last updated
3 Sep 2012
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing no-intubated thoracic epidural anesthesia and double-lumen endotracheal intubated anesthesia in people with Anaesthesia and Video Assisted Thoracic Surgery, run by Guangzhou Institute of Respiratory Disease at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Sep 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jun Liu, MD. (13808880646, cuidavil@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

recovery time after intervention of each group (time frame: 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in